Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DULAGLUTIDE Cause Product dose omission issue? 1,795 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,795 reports of Product dose omission issue have been filed in association with DULAGLUTIDE (Trulicity). This represents 2.4% of all adverse event reports for DULAGLUTIDE.

1,795
Reports of Product dose omission issue with DULAGLUTIDE
2.4%
of all DULAGLUTIDE reports
1
Deaths
86
Hospitalizations

How Dangerous Is Product dose omission issue From DULAGLUTIDE?

Of the 1,795 reports, 1 (0.1%) resulted in death, 86 (4.8%) required hospitalization, and 3 (0.2%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DULAGLUTIDE. However, 1,795 reports have been filed with the FAERS database.

What Other Side Effects Does DULAGLUTIDE Cause?

Injection site pain (9,474) Nausea (9,137) Blood glucose increased (9,119) Incorrect dose administered (5,207) Diarrhoea (5,036) Vomiting (4,880) Inappropriate schedule of product administration (3,606) Extra dose administered (3,047) Injection site haemorrhage (3,028) Weight decreased (3,000)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which DULAGLUTIDE Alternatives Have Lower Product dose omission issue Risk?

DULAGLUTIDE vs DULERA DULAGLUTIDE vs DULOXETINE DULAGLUTIDE vs DUPILUMAB DULAGLUTIDE vs DURAGESIC DULAGLUTIDE vs DUROGESIC

Related Pages

DULAGLUTIDE Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue DULAGLUTIDE Demographics